TrialClinical interventions in aging2018

An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin.

Pei-Shan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.